Citation: | JI Wenqing, YU Cui, LV Yane, YANG Yaying, HU Juan. Imaging Diagnosis and Research Progress of Pancreatic Neuroendocrine Tumors[J]. CT Theory and Applications, 2021, 30(5): 653-659. DOI: 10.15953/j.1004-4140.2021.30.05.14 |
[1] |
BATCHER E, MADAJ P, GIANOUKAKIS A G. Pancreatic neuroendocrine tumors[J]. Endocrine Research, 2011, 36(1):35-43. DOI: 10.3109/07435800.2010.525085.
|
[2] |
FANG J M, SHI J. A clinicopathologic and molecular update of pancreatic neuroendocrine neoplasms with a focus on the new world health organization classification[J]. Archives of Pathology Laboratory Medicine, 2019, 143(11):1317-1326. DOI: 10.5858/arpa.2019-0338-RA.
|
[3] |
CHEN L J, HAN Y D, ZHANG M. Diagnosis value preoperative localization of insulinoma by diffusion-weighted imaging:A pilot study[J]. Medicine (Baltimore), 2020, 99(49):23-48. DOI: 10.1097/MD.0000000000023048.
|
[4] |
NAGTEGAAL I D, ODZE R D, KLIMSTRA D. The 2019 WHO classification of tumours of the digestive system[J]. Histopathology, 2020, 76(2):182-188. DOI: 10.1111/his.1397.
|
[5] |
BELOTTO M, CROUZILLARD BDNS, ARAUJO K O, et al. Pancreatic neuroendocrine tumors:Surgical resection[J]. Arquivos Brasileiros de Cirurgia Digestiva, 2019, 32(1):1428. DOI:/10. 1590/0102-672020180001e1428.
|
[6] |
BOUTSEN L, JOURET-MOURIN A, BORBATH I, et al. Accuracy of pancreatic neuroendocrine tumour grading by endoscopic ultrasound-guided fine needle aspiration:Analysis of a large cohort and perspectives for improvement[J]. Neuroendocrinology, 2018, 106(2):158-166. DOI:10. 1159/000477213.
|
[7] |
ÖBERG K, KNIGGE U, KWEKKEBOOM D, et al. Gastroenteropancreatic neuroendocrine neoplasms:ESMO clinical practice guidelines for diagnosis, treatment and follow-up[J]. Annals of Oncology, 2012, 23(S7):124-130. DOI: 10.1093/annonc/mds295.
|
[8] |
ERIC P T, PRIYA B, JEFFREY H L. State-of-the-art imaging of pancreatic neuroendocrine tumors[J]. Surgical Oncology Clinics of North America, 2016, 25(2):375-400. DOI:10.1016/j. soc.2015.11.007.
|
[9] |
刘黎明, 唐艳华, 王海屹, 等. 多层CT对胰腺神经内分泌肿瘤病理分级的可行性[J]. 中华放射学杂志, 2016, 50(2):105-109.
LIU L M, TANG Y H, WANG H Y, et al. CT imaging features of different histological grades of pancreatic neuroendocrine tumors[J]. Chinese Journal of Radiology, 2016, 50(2):105-109. (in Chinese).
|
[10] |
KIM D W, KIM H J, KIM K W, et al. Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT:Comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour[J]. European Journal of Radiology, 2015, 25(5):1375-1383. DOI:10.1007/s00330- 014-3532-z.
|
[11] |
HORIGUCHI S, KATO H, SHIRAHA H, et al. Dynamic computed tomography is useful for prediction of pathological grade in pancreatic neuroendocrine neoplasm[J]. Journal of Gastroenterol and Hepatol, 2017, 32(4):925-931. DOI: 10.1111/jgh.13594.
|
[12] |
敖炜群, 王培军, 杨光钊, 等. 囊实性胰腺神经内分泌肿瘤的CT和MRI表现与病理分级对照[J]. 医学影像学杂志, 2016, 26(5):843-847.
AO W Q, WANG P J, YANG G Z, et al. Cystic-solid pancreatic neuroendocrine tumors-correlation of CT and MRI findings with pathological classification[J]. Journal of Medical Imagine, 2016, 26(5):843-847. (in Chinese).
|
[13] |
YAMAMOTO Y, OKAMURA Y, UEMURA S, et al. Vascularity and tumor size are significant predictors for recurrence after resection of a pancreatic neuroendocrine tumor[J]. Annals of Surgical Oncology, 2017, 24(8):2363-2370. DOI: 10.1245/s10434-017-5823-5.
|
[14] |
章伟, 郏潜新, 蒋政焱, 等. CT灌注成像在胰腺浆液性囊腺瘤与良性神经内分泌肿瘤鉴别的价值[J]. 实用放射学杂志, 2020, 36(12):1965-1968.
ZHANG W, JIA Q X, JIANG Z Y, et al. The value of CT perfusion imaging in the differentiation of serous cystadenoma and benign neuroendocrine neoplasms of the pancreas[J]. Journal of Practical Radiology, 2020, 36(12):1965-1968. (in Chinese).
|
[15] |
裴响. 动脉期低强化型胰腺神经内分泌肿瘤CT表现分析[J]. 影像研究与医学应用, 2019, 3(7):204-205.
|
[16] |
KANG J, RYU J K, SON J H, et al. Association between pathologic grade and multiphase computed tomography enhancement in pancreatic neuroendocrine neoplasm[J]. Journal of Gastroenterol and Hepatol, 2018, 33(9):1677-1682. DOI: 10.1111/jgh.14139.
|
[17] |
YAMADA S, FUJⅡ T, SUZUKI K, et al. Preoperative identification of a prognostic factor for pancreatic neuroendocrine tumors using multiphase contrast-enhanced computed tomography[J]. Pancreas, 2016, 45(2):198-203. DOI:10.1097/MPA. 0000000000000443.
|
[18] |
林晓珠, 李卫侠, 朱延波, 等. 宝石能谱CT在肿瘤诊断中的初步应用[J]. 诊断学理论与实践, 2010, 9(2):155-160.
LIN X Z, LI W X, ZHU Y B, et al. Preliminary application of gemstone spectral imaging (GSI) in the diagnosis of tumors[J]. Journal of Diagnostics Concepts and Practice, 2010, 9(2):155-160. (in Chinese).
|
[19] |
罗春材, 李涛, 杨立. 双层探测器能谱CT的特点及临床应用[J]. 中国医疗设备, 2021, 36(7):170-173.
LUO C C, LI T, YANG L. Characteristics and clinical application of two-layer detector energy spectrum CT[J]. China Medical Devices, 2021, 36(7):170-173. (in Chinese).
|
[20] |
LIN X Z, WU Z Y, TAO R, et al. Dual energy spectral CT imaging of insulinoma-value in preoperative diagnosis compared with conventional multi-detector CT[J]. European Journal of Radiology, 2012, 81(10):2487-2494. DOI: 10.1016/j.ejrad.2011.10.028.
|
[21] |
TAMM E P, BHOSALE P, LEE J H, et al. State-of-the-art imaging of pancreatic neuroendocrine tumors[J]. Surgical Oncology Clinics of North America, 2016, 25(2):375-400. DOI: 10.1016/j.soc.2015.11.007.
|
[22] |
DROMAIN C, DÉANDRÉIS D, SCOAZEC J Y, et al. Imaging of neuroendocrine tumors of the pancreas[J]. Diagnostic and Interventional Imaging, 2016, 97(12):1241-1257. DOI:10.1016/j.diii.2016. 07.012.
|
[23] |
SALEH M, BHOSALE PR, YANO M, et al. New frontiers in imaging including radiomics updates for pancreatic neuroendocrine neoplasms[J]. Abdominal Radiology, 2020:1-23. DOI: 10.1007/s00261-020-02833-8.
|
[24] |
LO G C, KAMBADAKONE A. MR imaging of pancreatic neuroendocrine tumors[J]. Magnetic Resonance Imaging Clincis North America, 2018, 26(3):391-403. DOI: 10.1016/j.mric.2018.03.010.
|
[25] |
KULALI F, SEMIZ-OYSU A, DEMIR M, et al. Role of diusion-weighted MR imaging in predicting the grade of nonfunctional pancreatic neuroendocrine tumors[J]. Diagnostic and Interventional Imaging, 2018, 99(5):301-309. DOI: 10.1016/j.diii.2017.10.012.
|
[26] |
KIM J H, EUN H W, KIM Y J, et al. Pancreatic neuroendocrine tumour (PNET):Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma[J]. European Radiology, 2016, 26(5):1338-1347. DOI: 10.1007/s00330-015-3941-7.
|
[27] |
De ROBERTIS R, CINGARLINI S, TINAZZI MARTINI P, et al. Pancreatic neuroendocrine neoplasms:Magnetic resonance imaging features according to grade and stage[J]. World Journal of Gastroenterology, 2017, 23(2):275-285. DOI: 10.3748/wjg.v23.i2.275.
|
[28] |
De ROBERTIS R, D'ONOFRIO M, ZAMBONI G, et al. Pancreatic neuroendocrine neoplasms:Clinical value of diffusion-weighted imaging[J]. Neuroendocrinology, 2016, 103(6):758-770. DOI:10. 1159/000442984.
|
[29] |
KIM J H, EUN H W, KIM Y J, et al. Staging accuracy of MR for pancreatic neuroendocrine tumor and imaging findings according to the tumor grade[J]. Abdominal Imaging, 2013, 38(5):1106-1114. DOI: 10.1007/s00261-013-0011-y.
|
[30] |
GUO C, CHEN X, XIAO W, et al. Pancreatic neuroendocrine neoplasms at magnetic resonance imaging:Comparison between grade 3 and grade 1/2 tumors[J]. Onco Targets and Therapy, 2017, 10:1465-1474. DOI: 10.2147/OTT.S127803.
|
[31] |
FARCHIONE A, RUFINI V, BRIZI M G, et al. Evaluation of the added value of diffusionweighted imaging to conventional magnetic resonance imaging in pancreatic neuroendocrinetumors and comparison with 68Ga-DOTANOC positron emission tomography/computed tomography[J]. Pancreas, 2016, 45(3):345-354. DOI: 10.1097/MPA.0000000000000461.
|
[32] |
PEREIRA J A, ROSADO E, BALI M, et al. Pancreatic neuroendocrine tumors:Correlation between histogram analysis of apparent diffusion coefficient maps and tumor grade[J]. Abdominal Imaging, 2015, 40:3122-3128. DOI: 10.1007/s00261-015-0524-7.
|
[33] |
CANELLAS R, LO G, BHOWMIK S, et al. Pancreatic neuroendocrine tumor:Correlations between MRI features, tumor biology, and clinical outcome after surgery[J]. Journal of Magnetic Resonance Imaging, 2018, 47(2):425-432. DOI: 10.1002/jmri.25756.
|
[34] |
LOTFALIZADEH E, RONOT M, WAGNER M, et a1. Prediction of pancreatic neuroendocrine tumour grade with MR imaging features:Added value of diffusion-weighted imaging[J]. European Radiology, 2017, 27(4):1748-1759. DOI: 10.1007/s00330-016-4539-4.
|
[35] |
马永华, 张荣坤, 岳都金. 胰腺神经内分泌肿瘤的MRI特征[J]. 医学影像学杂, 2020, 30(5):896-899.
MA Y H, ZHANG R K, YUE D J. Componative analysis of MRI features and pathology of pancreatic neuroendcrime tomors[J]. Journal of Medical Imagine, 2020, 30(5):896-899. (in chinese).
|
[36] |
WANG Z, CHEN X, WANG J, et al. Differentiating hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma based on CT texture analysis[J]. Acta Radiology, 2020, 61(5):595-604. DOI: 10.1177/0284185119875023.
|
[37] |
YANO M, MISRA S, CARPENTER D H, et al. Pancreatic neuroendocrine tumors:Computed tomography enhancement, but not histological grade, correlates with tumor aggression[J]. Pancreas, 2017, 46(10):1366-1372. DOI: 10.1097/MPA.0000000000000922.
|
[38] |
肖波. 主胰管绕道征-胰腺神经内分泌肿瘤的一个重要MRI征象[J]. 磁共振成像, 2015, 6(3):194-198.
XIAO B. The bypass sign of main pancreatic duct:A significant MRI sign of pancreatic neuroendocrine tumors[J]. Chinese Journal of Magnetic Resonance Imaging, 2015, 6(3):194-198. (in Chinese).
|
[39] |
D'ASSIGNIES G, FINA P, BRUNO O, et al. High sensitivity of diffusion-weighted MR imaging for the detection of liver metastases from neuroendocrine tumors:Comparison with T2-weighted and dynamic gadolinium-enhanced MR imaging[J]. Radiology, 2013, 68(2):390-399. DOI:10. 1148/radiol.13121628.
|
[40] |
赵娓娓, 任静, 印弘, 等. DCE-MR在胰腺神经内分泌肿瘤术前分级中的应用[J]. 放射学实践, 2017, 32(10):1003-1007.
ZHAO W W, REN J, YIN H, et al. Value of dynamic contrast-enhanced MRI (DCE-MRI) in the grading of pancreatic neuroendocrine tumors[J]. Radiologic Practice, 2017, 32(10):l003-1007. (in Chinese).
|
1. |
黄晓颖,李霞敏,郭方凯,王鹏朝,单春辉,暴云锋. 低剂量CT灌注联合双能扫描在胰腺神经内分泌肿瘤中的应用. CT理论与应用研究(中英文). 2025(03): 369-375 .
![]() |